%D8%B3%D8%B1%D8%B7%D8%A7%D9%86_%D8%AD%D8%B3%D8%A7%D8%B3_%D9%84%D9%84%D9%87%D8%B1%D9%85%D9%88%D9%86%D8%A7%D8%AAHormone-sensitive_cancer%E0%AE%B9%E0%AE%BE%E0%AE%B0%E0%AF%8D%E0%AE%AE%E0%AF%8B%E0%AE%A9%E0%AF%8D_%E0%AE%89%E0%AE%A3%E0%AE%B0%E0%AF%8D%E0%AE%A4%E0%AE%BF%E0%AE%B1%E0%AE%A9%E0%AF%8D_%E0%AE%AA%E0%AF%81%E0%AE%B1%E0%AF%8D%E0%AE%B1%E0%AF%81%E0%AE%A8%E0%AF%8B%E0%AE%AF%E0%AF%8DQ28136285
about
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancerCausal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving SurgeryThe role of gonadotrophin-releasing hormone antagonists in the treatment of patients with advanced hormone-dependent prostate cancer in the UKOestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer.Clinical pharmacology and regulatory consequences of GnRH analogues in prostate cancerMinimizing early relapse and maximizing treatment outcomes in hormone-sensitive postmenopausal breast cancer: efficacy review of AI trials.CYP17 blockade by abiraterone: further evidence for frequent continued hormone-dependence in castration-resistant prostate cancer.Hormone-associated cancer: mechanistic similarities between human breast cancer and estrogen-induced kidney carcinogenesis in hamsters.Estradiol metabolism: an endocrine biomarker for modulation of human mammary carcinogenesis.Endogenous estrogens and breast cancer risk: the case for prospective cohort studies.Medical hypothesis: bifunctional genetic-hormonal pathways to breast cancerPotential utility of natural products as regulators of breast cancer-associated aromatase promotersTargeting oestrogen to kill the cancer but not the patient.The discovery and mechanism of action of letrozole.The patient experienceSafety of aromatase inhibitors in the adjuvant setting.Mitogenic regulation of normal and malignant breast epithelium.Androgen deprivation therapy as adjuvant/neoadjuvant to radiotherapy for high-risk localised and locally advanced prostate cancer: recent developments.Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis.New endocrine agents, guidelines for future development.
P921
Q24657145-BF5D1AAD-5F84-4B83-BEDE-8D11753121A1Q26824799-7FEEC5CF-566A-4DC3-9CF4-181137232339Q28069804-7FDB3654-6803-46D9-88A9-389138E8F275Q28072710-11F9DA9B-2357-4703-A697-CD597C2AA834Q33842800-33F42DD6-D4E7-4C4B-AC87-5F05349774ADQ34104391-33C85230-D8A5-4D2E-A42C-EC953E2131A2Q34233815-4256EB2D-77DA-4DD6-8C0F-3491F3D55DC7Q34604646-A49AC4D2-9651-4F02-A0B6-FD08A4CD20BFQ34638087-4F97FDA4-5301-471E-98F1-AE8CB6ACB1B0Q34638093-CC0452CD-B176-4973-B284-1AEA2D704126Q34638131-B080B70B-A676-4996-8778-945DBE71C879Q34638169-39570F89-818F-4592-961D-85640679A71DQ35124690-7AB3577C-0D38-4CDF-A070-1F5FB80B0018Q35680855-BB5BE315-2BF7-4972-937C-18129029E992Q36026408-AF58C48A-561B-4685-8A05-9DEE16FDCFE6Q36026414-E70CEEDE-660E-45FF-890B-5A3B63ED723DQ36026543-C6E6EF16-A017-44A6-865E-1206F56A7389Q36987868-00139555-ABA0-401A-A345-DDEBF0F688C4Q37947081-F7EE7CB4-BE93-4DAB-A9C1-FAEC8D35CB38Q38643713-473DE801-4EBD-466E-B291-39E46BBB8209Q38677690-A8076A6C-A1AE-4110-BDD1-FB5B6C7684CE
P921
description
a type of cancer dependent on a hormone for growth
@en
name
Hormone-sensitive cancer
@en
cancer hormono dépendant
@fr
سرطان حساس للهرمونات
@ar
ஹார்மோன் உணர்திறன் புற்றுநோய்
@ta
type
label
Hormone-sensitive cancer
@en
cancer hormono dépendant
@fr
سرطان حساس للهرمونات
@ar
ஹார்மோன் உணர்திறன் புற்றுநோய்
@ta
altLabel
Tumeur hormonodépendante
@fr
prefLabel
Hormone-sensitive cancer
@en
cancer hormono dépendant
@fr
سرطان حساس للهرمونات
@ar
ஹார்மோன் உணர்திறன் புற்றுநோய்
@ta